Related references
Note: Only part of the references are listed.Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides
Michael E. Ostergaard et al.
NUCLEIC ACIDS RESEARCH (2020)
Targeting long non-coding RNA MALAT1 alleviates retina neurodegeneration in diabetic mice
Yu-Lan Zhang et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2020)
The powerful world of antisense oligonucleotides: From bench to bedside
Anais M. Quemener et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
Volatile Evolution of Long Non-Coding RNA Repertoire in Retinal Pigment Epithelium: Insights from Comparison of Bovine and Human RNA Expression Profiles
Olga A. Postnikova et al.
GENES (2019)
Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia
Kimberly L. Spooner et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
Naoki Iwamoto et al.
NATURE BIOTECHNOLOGY (2017)
Long non-coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling
Jin Yao et al.
EMBO MOLECULAR MEDICINE (2016)
The Medicinal Chemistry of Therapeutic Oligonucleotides
W. Brad Wan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation
Radulfus WN Slijkerman et al.
Molecular Therapy-Nucleic Acids (2016)
Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
Tobias Bonifert et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration
Susan F. Murray et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Antisense oligonucleotides: modifications and clinical trials
Vivek K. Sharma et al.
MEDCHEMCOMM (2014)
Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus
J-Y Liu et al.
CELL DEATH & DISEASE (2014)
Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
Fritz Eckstein
NUCLEIC ACID THERAPEUTICS (2014)
Characterization of Target mRNA Reduction Through In Situ RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in Animals
Gene Hung et al.
NUCLEIC ACID THERAPEUTICS (2013)
Antisense Oligonucleotide (AON)-based Therapy for Leber Congenital Amaurosis Caused by a Frequent Mutation in CEP290
Rob W. J. Collin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Stereocontrolled Solid-Phase Synthesis of Oligonucleoside H-Phosphonates by an Oxazaphospholidine Approach
Naoki Iwamoto et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains
John N. Hutchinson et al.
BMC GENOMICS (2007)
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
Eric E. Swayze et al.
NUCLEIC ACIDS RESEARCH (2007)
Share Paper
